6-Hydroxy-2(1H)-3,4-dihydroquinolinone
|
|
- CAS-Nr.
- 54197-66-9
- Englisch Name:
- 6-Hydroxy-2(1H)-3,4-dihydroquinolinone
- Synonyma:
- 6-HYDROXY-3,4-DIHYDROQUINOLIN-2(1H)-ONE;6-HYDROXY-3,4-DIHYDRO-2(1H)-QUINOLINONE;Q-2;6-HQ;in-2(1H)-one;AURORA KA-4814;6-Hydroxy-2-oxo-1;Cilostazol USP RC A;4-tetrahydroquinoline;Brexpiprazole Impurity 72
- CBNumber:
- CB9143232
- Summenformel:
- C9H9NO2
- Molgewicht:
- 163.17
- MOL-Datei:
- 54197-66-9.mol
|
6-Hydroxy-2(1H)-3,4-dihydroquinolinone Eigenschaften
- Schmelzpunkt:
- 236-240 °C
- Siedepunkt:
- 424.5±45.0 °C(Predicted)
- Dichte
- 1.282±0.06 g/cm3(Predicted)
- storage temp.
- Sealed in dry,Room Temperature
- L?slichkeit
- DMSO (Slightly), Methanol (Slightly, Heated)
- pka
- 9.86±0.20(Predicted)
- Aggregatzustand
- solid
- Farbe
- White to Almost white
- CAS Datenbank
- 54197-66-9(CAS DataBase Reference)
6-Hydroxy-2(1H)-3,4-dihydroquinolinone Chemische Eigenschaften,Einsatz,Produktion Methoden
R-S?tze Betriebsanweisung:
R36/37/38:Reizt die Augen, die Atmungsorgane und die Haut.
S-S?tze Betriebsanweisung:
S26:Bei Berührung mit den Augen sofort gründlich mit Wasser abspülen und Arzt konsultieren.
Chemische Eigenschaften
6-Hydroxy-2(1H)-3,4-dihydroquinolinone Appearance is white to almost white powder to crystal, Melting point 238°C, Store at -20° C.
Verwenden
A metabolite of Cilostazole.
6-Hydroxy-2(1H)-3,4-dihydroquinolinone Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
6-Hydroxy-2(1H)-3,4-dihydroquinolinone Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 389)Lieferanten
54197-66-9()Verwandte Suche:
- 6-HYDROXY-3,4-DIHYDRO-1H-QUINOLIN-2-ONE
- TQ(3,4-Dihydro-6-Hydroxy-2(1H)CQuinolinone)
- TQ(3,4-DIHYDRO-6-HYDROXY-2(1H)QUINOLINONE)
- Hydroxyl-3,4-dihydrocarbostyril
- 6-Hydroxy-1,2,3,4-tetrahydro-2-quinolinone, 6-Hydroxy-3,4-dihydrocarbstyril
- 3,4-Dihydro-2,6-quinolinediol
- 3,4-Dihydro-6-hydroxyquinoline-2(1H)-one
- 6-Hydroxy-3,4-dihydroquinoline-2(1H)-one
- AURORA KA-4814
- 2(1H)-Quinolinone, 3,4-dihydro-6-hydroxy-
- 6-Hydroxy-3,4-dihydro-2(1H)-quinolinone,6-Hydroxy-1,2,3,4-tetrahydro-2-quinolinone, 6-Hydroxy-3,4-dihydrocarbstyril
- 4-tetrahydroquinoline
- 6-Hydroxy-2-oxo-1
- Cilostazol Related Compound A (50 mg) (6-hydroxy-3,4-dihydro-1H-quinolin-2-one)
- 6-Hydroxy-3,4-dihydro-2(1H)-quinolinone
6-Hydroxy-2-oxo-1,2,3,4-tetrahydroquinoline
- Cilostazol Related CoMpound A
- 6-hydroxy-3,4-dihydroquinazolone
(Cilostazol)
- 6-Hydroxy-3,4-dihydro-2(1H)-quinolinone
- 6-Hydroxy-3,4-dihydro-2(1H)-quinolinone 97%
- 3,4-Dihydro-6-hydroxy-2(1H)-quinolinone
- 3,4-DIHYDRO-6-HYDROXYQUINOLINONE
- 3,4-DIHYDRO-6-HYDROXY-2(1H)-QUINOLINONE
- 6-HYDROXY-2-OXO-1,2,3,4-TETRAHYDROQUINOLINE (6-HQ)
- 6-Hydroxyl-3.4-dihydro-2-(1H)-quinolinone
- Intermediate of Cilostazol
- 6-HYDROXY-3,4-DIHYDRO-2-QUINOLINONE
- 6-HYDROXY-3,4-DIHYDROCARBOSTYRIL
- 6-HYDROXY-3,4-DIHYDROCARBSTYRIL
- 6-HYDROXY-2-OXO-1,2,3,4-TETRAHYDROQUINOLINE
- 6-HYDROXY-3,4-DIHYDROQUINOLONE
- 3,4-Dihydro-6-hydroxycarbostyril
- 3,4-Dihydro-6-hydroxy-carbostyril
- 6-Hydroxy-2-oxo-1,2,3,4-tetrahydroquinolin
- 6-Hydroxy-3,4-dihydro-1H-quinoline-2-one
- 3,4-Dihydro-6-hydroxyquinolin-2(1H)-one
- 6-HYDROXY-2(1H)-3,4-DIHYDROQUINOLINONE CILOSTAZOL INTERMEDIATE
- 6-HIDROXY-2(1H)-3,4-DIHYDROQUINOLINONE
- 6-HYDRO-2(1H)-3,4-DIHYDROQUINOLINONE
- 6-Hydroxy-1,3,4-trihydroquinolin-2-one
- 6-HYDROXY-1,2,3,4-TETRAHYDRO-2-QUINOLINONE
- 6-HYDROXY-2(1H)-3,4-DIHYDROQUINOLINONE
- 6-HQ
- 6-HYDROXYL-3,4-DIHYDROCARBOSTYRIL
- The intermediate of Cilostazol
- 3,4-Dihydro-6-hydroxy-2-(IH)-quinolinone
- 6-Hydroxy-1,2,3,4-tetrahydro-2-oxoquinoline
- Hydroxyl-3,4-Dihydrocarbostyril(ForCilostazol)
- Q-2
- 3,4-Dihydro-6-hydroxycarbostyril-2(1H)quinolinone
- Cilostazol USP Related Compound A
- Brexpiprazole Impurity 72
- 6-Hydroxy-3,4-Dihydroquinolinone(For Cilostazol)
- 3,4-Dihydro-6-hydroxyquinolin-2(1H)-one 98%
- 1,2,3,4-Tetrahydro-6-hydroxy-2-oxoquinoline
- 6-Hydroxy-2(1H)-3,4-dihydroquinolinone
(Cilostazol)
- 6-Hydroxy-3,4-dihydro-1H-quinolin-2
- 3,4-Dihydro-6-hydroxy-2(1H)-quinolinone>
- 6-hydroxy-3,4-dihydroquinoL